Injection Lipolysis

SKU:

CA$125.00

CA$125.00

Unavailable

per item

Qty

Description

Injection Lipolysis is a body contouring option along with medically managed weight loss and Non-invasive options like Fotona TightSculpting. When administered by the right medical professionals, Injection Lipolysis can help women and men melt off excess fat deposits in many target areas of the body prone to fat accumulation.

Injection Lipolysis uses a mixture of Phosphatidylcholine and Deoxycholic acid. Phosphatidylcholine is a fatty acid that is extracted from the soya plant, phosphatidylcholine (lecithin). This is a natural product that is actually produced by your own body in areas such as the lungs, cells, and liver. When injected into the desired area, it literally melts away the fat by destroying fat cell membranes and reducing the thickness of fat deposits in a series of a few sessions.

Deoxycholic acid, which is a a bile acid which emulsifies and solubilizes dietary fats in the intestine, and when injected subcutaneously, it disrupts cell membranes in adipocytes and destroys fat cells in that tissue. In April 2015, deoxycholic acid was approved by the FDA for the treatment submental fat to improve aesthetic appearance and reduce facial fullness or convexity. It is the first pharmacological agent available for submental fat reduction, allowing for a safer and less invasive alternative than surgical procedures.

Areas that can be treated:
Abdomen
Flanks
Double chin
Back and Bra rolls
Outer thigh
Inner thigh
Jowls
Upper arms
Neck
Knees
Gluteal fold or Banana roll

Side effects
Post Injection Pain
Immediate redness at the injection site
Stinging and burning
Swelling
Bruising
Nausea
Diarrhea
Small hematomas at the injection site
Hives
Dizziness/light-headedness

• Facebook
• Twitter
• Pinterest
• Google+

Add to Cart

Clinical Safety data for Injection Lipolysis.

There is increasing interest in injection lipolysis as a technique for reducing small, localized fat deposits. While many articles have been published about injection lipolysis, none specifically address safety issues. A clinical safety data survey was sent to physicians practicing injection lipolysis. Seventy-five physicians from 17 countries responded. Data from the treatment of 17,376 patients who underwent a total of 56,320 injection sessions were analyzed. Among the topics reviewed in the survey were indications and contraindications for treatment, best and worst areas for treatment, and additives to the formula and their efficacy. Expected sequelae were differentiated from unexpected complications.

​The safety data collected here indicate that, when practiced by licensed and certified physicians, the safety record for injection lipolysis is excellent. There were no deaths or hospitalizations resulting from treatment. There were also no bacterial or atypical mycobacterial infections, no reports of skin loss or ulceration, and no episodes of dermatitis or chronic skin irritation. Among the 17,376 patients treated, 0.0021% experienced transient hyperpigmentation, 0.015% had persistent pain beyond 2 weeks posttreatment, 0.0003% had a late allergic reaction, and 0.00006% had a contour irregularity requiring additional injection treatment. Disappointment at a less-than-expected aesthetic result was expressed by 12.34% of patients.

There was consensus among responding physicians on the need for pretreatment patient education regarding realistic expectations. This survey is a representative, not definitive, survey of treatment results that is intended to serve as a starting point for further development and improvement of injection lipolysis technique.

​(Aesthetic Surg J 2006;26:575–585.)